Gestadienol

Gestadienol
Clinical data
Other namesNorhydroxy-δ6-progesterone; 6-Dehydro-17α-hydroxy-19-norprogesterone; 17α-Hydroxy-19-norpregn-4,6-diene-3,20-dione
Identifiers
  • (8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-13-methyl-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H26O3
Molar mass314.425 g·mol−1
3D model (JSmol)
  • CC(=O)C1(CCC2C1(CCC3C2C=CC4=CC(=O)CCC34)C)O
  • InChI=1S/C20H26O3/c1-12(21)20(23)10-8-18-17-5-3-13-11-14(22)4-6-15(13)16(17)7-9-19(18,20)2/h3,5,11,15-18,23H,4,6-10H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1
  • Key:GDTZPEHTYWXYAR-XGXHKTLJSA-N

Gestadienol (INNTooltip International Nonproprietary Name), also known as 6-dehydro-17α-hydroxy-19-norprogesterone, is a steroidal progestin of the 19-norprogesterone group that was never marketed.[1][2]

See also

References

  1. ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 659–. ISBN 978-1-4757-2085-3.
  2. ^ World Health Organization (2013), The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (PDF), p. 95, archived from the original (PDF) on August 8, 2016